GLSIGreenwich LifeSciences, Inc.
Earnings
When Greenwich LifeSciences, Inc. reports, what it reported each quarter, and how the stock took the results.
31 quarters. Mar 31, 2019 to Sep 30, 2026. mixed units.
Next results · Q4 2026Projected
10-K due Mar 29 – Apr 19
No earnings release is on file for this company, so the day is the 10-K’s, projected from its last 6 filings.
- Quarter
- Q4 2026 · Ends about Dec 31, 2026
- 10-K window
- Mar 29 – Apr 19
Read against Q4 2025
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
- Revenue
- —
- Net income
- -$9.15M
- Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
- EPS
- —
- EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m
Latest results
- Q3 2026Nov 16, 2026, after the close
- Revenue
- —
- —
- Net income
- -$5.81M
- N/M
- EPS
- -$0.40
- N/M
- Revenue
- —
- —
- Net income
- -$3.95M
- N/M
- EPS
- -$0.27
- N/M
- Revenue
- —
- —
- Net income
- -$5.66M
- N/M
- EPS
- -$0.39
- N/M
- Revenue
- —
- —
- Net income
- -$9.15M
- N/M
- EPS
- —
- —
All quarters
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Move | Source trail |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | ||||||||||
| Q3 2026 | Sep 30, 2026 | — | Nov 16, 2026 | 47 d | 10-Q | — | — | -$0.40 | — | |
| Q2 2026 | Jun 30, 2026 | — | Aug 11, 2026 | 42 d | 10-Q | — | — | -$0.27 | +8.8% | |
| Q1 2026 | Mar 31, 2026 | — | Jun 4, 2026 | 65 d | 10-Q | — | — | -$0.39 | 2.6% | |
| FY 2025 | ||||||||||
| Q4 2025derived | Dec 31, 2025 | — | Jun 1, 2026 | 152 d | 10-K | — | — | — | 14.8% | |
| Q3 2025 | Sep 30, 2025 | — | Nov 14, 2025 | 45 d | 10-Q | — | — | -$0.27 | 1.1% | |
| Q2 2025 | Jun 30, 2025 | — | Aug 14, 2025 | 45 d | 10-Q | — | — | -$0.28 | +0.4% | |
| Q1 2025 | Mar 31, 2025 | — | May 20, 2025 | 50 d | 10-Q | — | — | -$0.21 | 5.5% | |
| FY 2024 | ||||||||||
| Q4 2024derived | Dec 31, 2024 | — | Apr 15, 2025 | 105 d | 10-K | — | — | — | 1.2% | |
| Q3 2024 | Sep 30, 2024 | — | Nov 14, 2024 | 45 d | 10-Q | — | — | -$0.20 | 0.5% | |
| Q2 2024 | Jun 30, 2024 | — | Aug 14, 2024 | 45 d | 10-Q | — | — | -$0.20 | +3.8% | |
| Q1 2024 | Mar 31, 2024 | — | May 20, 2024 | 50 d | 10-Q | — | — | -$0.19 | +3.5% | |
| FY 2023 | ||||||||||
| Q4 2023derived | Dec 31, 2023 | — | Apr 15, 2024 | 106 d | 10-K | — | — | — | — | |
| Q3 2023 | Sep 30, 2023 | — | Oct 19, 2023 | 19 d | 10-Q | — | — | -$0.19 | 4.8% | |
| Q2 2023 | Jun 30, 2023 | — | Aug 21, 2023 | 52 d | 10-Q | — | — | -$0.13 | — | |
| Q1 2023 | Mar 31, 2023 | — | May 22, 2023 | 52 d | 10-Q | — | — | -$0.17 | 1.2% | |
| FY 2022 | ||||||||||
| Q4 2022derived | Dec 31, 2022 | — | Mar 31, 2023 | 90 d | 10-K | — | — | — | 6.8% | |
| Q3 2022 | Sep 30, 2022 | — | Nov 14, 2022 | 45 d | 10-Q | — | — | -$0.18 | +11.8% | |
| Q2 2022 | Jun 30, 2022 | — | Aug 15, 2022 | 46 d | 10-Q | — | — | -$0.06 | 3.9% | |
| Q1 2022 | Mar 31, 2022 | — | May 20, 2022 | 50 d | 10-Q | — | — | — | 5.7% | |
| FY 2021 | ||||||||||
| Q4 2021derived | Dec 31, 2021 | — | Mar 21, 2022 | 80 d | 10-K | — | — | — | +4.3% | |
| Q3 2021 | Sep 30, 2021 | — | Nov 15, 2021 | 46 d | 10-Q | — | — | -$0.07 | 2.7% | |
| Q2 2021 | Jun 30, 2021 | — | Aug 13, 2021 | 44 d | 10-Q | — | — | -$0.06 | +0.5% | |
| Q1 2021 | Mar 31, 2021 | — | May 20, 2021 | 50 d | 10-Q | — | — | -$0.05 | — | |
| FY 2020 | ||||||||||
| Q4 2020derived | Dec 31, 2020 | — | Mar 31, 2021 | 90 d | 10-K | — | — | — | +1.8% | |
| Q3 2020 | Sep 30, 2020 | — | Nov 16, 2020 | 47 d | 10-Q | — | — | -$0.03 | — | |
| Q2 2020 | Jun 30, 2020 | — | — | — | — | — | — | -$0.02 | — | |
| Q1 2020 | Mar 31, 2020 | — | — | — | — | — | — | -$0.03 | — | |
| FY 2019 | ||||||||||
| Q4 2019derived | Dec 31, 2019 | — | — | — | — | — | — | — | — | |
| Q3 2019 | Sep 30, 2019 | — | — | — | — | — | — | -$1.15 | — | |
| Q2 2019 | Jun 30, 2019 | — | — | — | — | — | — | — | — | |
| Q1 2019 | Mar 31, 2019 | — | — | — | — | — | — | — | — | |
Earlier years, FY 2019 to FY 2023The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Source filings
Provenance
ProvenanceData status and checks
Greenwich LifeSciences, Inc. · CIK 1799788 · Engraved from SEC EDGAR